Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.
Saved in:
| Title: | Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up. |
|---|---|
| Authors: | Du XL; Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas Health Science Center at Houston, Houston, USA., Simpson LM; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA., Osani MC; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA., Yama JM; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA., Davis BR; Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, USA. |
| Source: | Journal of Alzheimer's disease & Parkinsonism [J Alzheimers Dis Parkinsonism] 2022; Vol. 12 (3). Date of Electronic Publication: 2022 Apr 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: OMICS Pub. Group Country of Publication: United States NLM ID: 101587593 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2161-0460 (Print) NLM ISO Abbreviation: J Alzheimers Dis Parkinsonism Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2161-0460 |
|---|
